Swapnil Gupta

Medical Director, Outpatient Psychiatry

Swapnil Gupta is a prominent psychiatrist and academic known for her research and clinical work in the field of psychiatry, particularly focusing on the concept of deprescribing—the systematic reduction of unnecessary medications. She serves as an Associate Professor and Medical Director of Ambulatory Psychiatry at Mount Sinai Morningside Hospital in New York City. Gupta's educational background includes training in both India and the United States, with significant experiences at Yale University and SUNY Downstate Medical Center.1 2 3

Academic and Professional Background

Education: Gupta completed her medical training at the Jawaharlal Institute of Postgraduate Medical Education and Research in India, followed by a residency in psychiatry at SUNY Downstate. She furthered her expertise with a fellowship at Yale-New Haven Medical Center.3 4
Research Focus: Initially, her research centered on the endocannabinoid system and its role in schizophrenia. Over time, she shifted her focus to deprescribing practices, advocating for a more judicious use of psychiatric medications to enhance patient outcomes.2 4

Contributions to Psychiatry

Gupta has authored numerous peer-reviewed articles and a key text titled Deprescribing in Psychiatry, which she co-authored with colleagues. This book is recognized as a foundational resource in the emerging field of deprescribing within psychiatry, aiming to promote safer medication practices.5 Her work emphasizes collaboration with patients to evaluate the necessity of their medications based on individual health needs and preferences.2 5

Current Roles

In addition to her teaching and clinical responsibilities, Gupta is actively involved in various professional organizations aimed at improving psychiatric research and practice. She serves on editorial boards and is engaged in developing educational materials related to deprescribing practices.1 2

Swapnil Gupta's contributions are significant in shaping contemporary psychiatric practices, particularly through her innovative approaches to medication management.